O’Melveny advised Beauty Farm. Clifford Chance has advised the joint sponsors. Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder. Beauty Farm...
Beauty Farm’s Hong Kong IPO and Listing
Jiangsu Eastern Shenghong’s US$718 Million Swiss GDR Listing
Clifford Chance and JunHe advised Jiangsu Eastern Shenghong Co., Ltd. on the deal. The transaction involved Jiangsu Eastern Shenghong Co., Ltd.’s global depository receipts (GDR) offering and listing...
Sipai Health Technology’s Hong Kong IPO and Listing
Clifford Chance advised the joint sponsors on the deal while O’Melveny represented Sipai Health Technology Co., Ltd, Eight Roads and F-Prime. The joint sponsors Morgan Stanley...
Arrail Group Limited’s US$88 Million Initial Public Offering
Harneys acted as British Virgin Islands and Cayman Islands counsel for the successful listing of the shares of Arrail Group Limited on the Main Board of...
Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
Hangzhou SF Intra-city Industrial Co., Ld.’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...
MicroTech Medical’s US$249 Million Initial Public Offering
Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction. The Hangzhou-based firm offers diabetes therapy and manufactures medical...
Dongguan Rural Commercial Bank’s US$1.2 Billion Hong Kong IPO
King & Wood Mallesons (KWM) advised Dongguan Rural Commercial Bank Co., Ltd., while Clifford Chance has advised the joint sponsors. Dongguan Rural Commercial Bank Co., Ltd....
Zylox-Tonbridge’s US$330 Million IPO and Listing on the Hong Kong Stock Exchange
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
AIA Group’s US$1.86 Billion Acquisition Of a 24.99% Stake In China Post Life
Clifford Chance has advised China Post Life on the deal, while Debevoise & Plimpton advised AIA Group. China Post Life sold a 24.99% stake, post investment,...
Bilibili Inc.’s $2.6 Billion Secondary Listing
Walkers acted as Cayman Islands counsel to Bilibili Inc. in connection with its US$2.6 billion global offering of 25 million shares on the Main Board of...
SciClone Pharmaceuticals’ Hong Kong Initial Public Offering And Listing
Clifford Chance, Maples and Calder JunHe advised SciClone Pharmaceuticals on its US$281 million initial public offering and listing on the main board of the Hong Kong...